Find Neuroscience News Here!
Saybrook Capital NC Decreases Stock Holdings in Johnson & Johnson $JNJ
Saybrook Capital NC trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,142 shares of the company’s stock after selling 2,798 shares during the quarter. Johnson & [...]
Brighton Jones LLC Purchases 3,807 Shares of Johnson & Johnson $JNJ
Brighton Jones LLC boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 7.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 57,751 shares of the company’s stock after purchasing an additional 3,807 shares during the quarter. Brighton Jones LLC’s [...]
Avidity Biosciences Enters Into Agreement To Be Acquired By Novartis AG
(MENAFN - PR Newswire) Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its early-stage precision ...
Novartis Agrees To Acquire Avidity Biosciences, An Innovator In RNA Therapeutics, Strengthening Its Late-Stage Neuroscience Pipeline
(MENAFN - GlobeNewsWire - Nasdaq) Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic ...
Bristol Myers Squibb Company $BMY Shares Sold by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. reduced its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 0.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 499,533 shares of the biopharmaceutical company’s stock after selling 4,616 shares during the quarter. Oppenheimer Asset Management [...]
New Hampshire Trust Has $1.15 Million Stock Position in Novartis AG $NVS
New Hampshire Trust raised its position in shares of Novartis AG (NYSE:NVS – Free Report) by 8.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,483 shares of the company’s stock after purchasing an additional 749 shares [...]
KFSHRC Advances Neurological Care With AI Powered Brain Implant
(MENAFN - EIN Presswire) EINPresswire / -- At King Faisal Specialist Hospital and Research Centre (KFSHRC), the frontier of neurology has begun to think for itself. In June 2025, surgeons implanted ...
Johnson & Johnson $JNJ Shares Sold by Interchange Capital Partners LLC
Interchange Capital Partners LLC decreased its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.8% during the 2nd quarter, Holdings Channel reports. The fund owned 4,518 shares of the company’s stock after selling 230 shares during the quarter. Interchange Capital Partners LLC’s holdings in Johnson & Johnson were worth $690,000 as of its [...]
Unicorn Longevity Startup 600And1 Launches Ambitious Path To Decode And Bioengineer The Biology Of Aging
(MENAFN - EIN Presswire) EINPresswire/ -- 600and1, a pioneering unicorn biotechnology company, is stepping into the spotlight with a transformative mission: to extend both human lifespan and ...
University of Texas Texas AM Investment Management Co. Acquires Shares of 10,845 Bristol Myers Squibb Company $BMY
University of Texas Texas AM Investment Management Co. bought a new position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 10,845 shares of the biopharmaceutical company’s stock, valued at approximately $502,000. A number of other [...]